This in-depth analysis will tell you which states are most critical to negotiate with for preferred drug status, what is the downside risk of a disadvantaged formulary position for each state, and what is the most likely Medicaid sales potential for your product in each state under various formulary scenarios.

The analysis also contains a contract breakeven model, indicating the cost-benefit of discounting your product at various levels to state Medicaid departments.

Medicaid Spillover Model

This program identifies spillover effects from the Medicaid segment to the commercial third-party segment by state in your product category. The output shows the magnitude of expected spillover for your product under various formulary scenarios.

We estimate the impact of a favorable formulary position on both Medicaid share and third-party commercial share, allowing you to make informed decisions with respect to Medicaid contracting.

Medicare Potential Model

This model will tell you the expected increase in demand for your product based on Medicare enrollees moving into a prescription drug benefit as either part of a Prescription Drug Plan or a Medicare Advantage Plan.

The program also contains a contract breakeven model, indicating the cost-benefit of discounting your product at various levels to Medicare Prescription Drug Plans (PDP) and health plans.

Sales & Share Trend Analysis

This popular analysis gives your product's market share and sale's volume performance by health plan and is customized to show account performance by sales region or account manager.

This analysis can be used to jump start a dialogue between account managers and field sales managers to target the best plans for growth as well as to present at regular plan-of-action meetings.

Health Plan Potential Model

Do you know the regular value of health plans that you are targeting for promotion and contracting? Our Plan Potential Model computes the potential business opportunity to your company and provides easy to read, easy to understand graphics.

›››  Health Economics